U.S. Urology Partners Signals Growth with New COO, Patient-Centric CXO Role

NASHVILLE, TN – August 03, 2026 – U.S. Urology Partners, a fast-growing network supporting community-based urology practices, has made a significant strategic move by appointing Jonathan Coggins as its new Chief Operating Officer. In a concurrent shift that underscores a deepening commitment to patient-centric care, longtime executive Mandy Lawrence will assume the newly created role of Chief Experience Officer (CXO). These leadership changes signal a dual focus on aggressively scaling operations across its 70+ locations while simultaneously setting a new standard for the patient journey in specialty medicine.

The Nashville-based organization, which is backed by global investor General Atlantic, has built its platform on a unique model: allowing independent urology practices to retain their local brand and clinical autonomy while gaining access to the robust operational, technological, and financial resources of a larger entity. This latest C-suite reshuffle is designed to fortify that value proposition as the company continues its national expansion.

A Dual Strategy: Scaling Operations While Elevating Patient Care

The appointments of Coggins and Lawrence are not isolated hires but rather a coordinated strategy to manage rapid growth without sacrificing quality. As the organization expands its footprint, which now spans seven states, the need for both operational excellence and a standardized, high-quality patient experience becomes paramount.

Corina Tracy, Chief Executive Officer of U.S. Urology Partners, emphasized the strategic alignment of the new appointments. “We are pleased to welcome Jonathan Coggins as Chief Operating Officer,” she stated. “Jonathan brings a proven record of leading strategy, growth and operational performance across healthcare organizations, and his experience is strongly aligned with our work to support independent, community-based urology practices. His leadership will help advance our best-in-class, integrated healthcare platform.”

Simultaneously, Lawrence’s transition to CXO addresses a critical component of modern healthcare delivery. With a background that combines a nursing degree with an MBA, Lawrence is tasked with designing a more “seamless, compassionate and coordinated patient journey.” This move reflects a broader industry trend toward value-based care, where patient satisfaction and positive outcomes are increasingly tied to a provider’s financial success. By creating a dedicated C-suite role for patient experience, U.S. Urology Partners is making a clear statement about its priorities.

Operational Powerhouse: Coggins to Drive Growth and Efficiency

Jonathan Coggins arrives at U.S. Urology Partners from McKesson Corporation, where he served as Senior Vice President of Strategy and Operations. His tenure there provides a clear roadmap for the value he is expected to bring. At McKesson, Coggins was instrumental in setting the strategic direction for its U.S. Oncology Network and launching the company's first fintech offering for community practices.

His experience in building Clarity Solutions, McKesson’s device group purchasing organization (GPO), from the ground up is particularly noteworthy. This background suggests Coggins will focus on leveraging U.S. Urology Partners’ collective scale to drive down costs for its affiliated practices, negotiating more favorable terms for everything from surgical devices to pharmaceuticals. For independent practices squeezed by rising overhead, such GPO-like benefits are a powerful incentive to join a larger network. Furthermore, his expertise in launching fintech services could translate into new revenue cycle management tools and financial solutions that alleviate administrative burdens and improve cash flow for partner practices.

“U.S. Urology Partners has built something rare—a platform that lets independent urology practices stay independent while giving physicians the resources to grow and patients the highest level of care,” Coggins stated. “I'm excited to partner with our practice leaders to build on that foundation and help even more communities access outstanding urologic care.” His extensive experience in post-merger integration, honed during his time at PricewaterhouseCoopers and Accenture, will also be critical as the company continues to affiliate with new practices, ensuring a smooth transition that preserves local culture while integrating operational best practices.

The Rise of the Experience Officer in Specialty Care

The creation of the Chief Experience Officer role and Mandy Lawrence’s appointment to it is perhaps the most forward-looking aspect of the company’s announcement. While common in retail and hospitality, the CXO is an emerging but vital position in healthcare. It signifies a shift from viewing patients as passive recipients of care to active consumers whose entire journey—from scheduling the first appointment to post-treatment follow-up—matters.

Lawrence’s mission will be to standardize excellence across every patient touchpoint within the diverse network of affiliated practices. This involves mapping the patient journey, identifying pain points, and implementing data-driven solutions. Initiatives may include streamlining appointment scheduling, improving communication through patient portals, reducing wait times, and ensuring that clinical interactions are not only effective but also empathetic. Her clinical background as a nurse provides an invaluable perspective on patient needs, while her MBA equips her to measure the return on investment for experience-related initiatives.

This focus is especially critical in urology, a field that deals with sensitive health issues and often requires long-term patient relationships. An exceptional experience can improve patient adherence to treatment plans, lead to better clinical outcomes, and build lasting loyalty. As one healthcare analyst noted, "In a competitive market, patient experience is no longer a 'soft' metric; it's a key differentiator that drives patient retention and practice growth."

Fueling the Independent Practice in a Consolidating Market

U.S. Urology Partners’ strategic leadership changes are set against a backdrop of intense pressure on independent medical practices. An aging U.S. population is increasing the demand for urological services, yet solo and small-group practices face significant headwinds, including complex regulatory compliance, declining reimbursement rates, and the high cost of adopting new technologies like robotic surgery and advanced diagnostics.

This is where the U.S. Urology Partners model, supercharged by its new leadership and the financial backing of General Atlantic, becomes a compelling alternative to being acquired by a hospital system. The company provides the back-office infrastructure—including business operations, data analytics, and IT support—that allows physicians to focus on practicing medicine. Recent strategic moves, such as the launch of an AI-powered clinical insight platform and expansion into New Jersey and Pennsylvania, demonstrate a commitment to providing cutting-edge tools and market access to its partners.

By bringing in an operational expert like Coggins to maximize efficiency and a dedicated CXO like Lawrence to perfect the service delivery, U.S. Urology Partners is strengthening its core promise: to help independent practices not only survive but thrive. The company is betting that this combination of preserved autonomy, operational muscle, and an unparalleled patient experience will be the winning formula for attracting the best community-based urology groups across the country.